US · Healthcare · Medical Devices
EPS came in at 2.48 against a street estimate of 2.31 — a beat of 7.4%.
Analysts rate UFP Technologies Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $324.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.18% |
| Congress Asset Management Company, LLP | 8.89% |
| Wasatch Advisors LP | 8.83% |
| BTIM Corp | 4.35% |
| Vanguard Capital Management, LLC | 4.22% |
| State Street Corp | 3.92% |
| Neuberger Berman Group LLC | 3.89% |
| T. Rowe Price Associates, Inc. | 3.19% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-06-10 |
| Reg FD disclosure · Q2 2026 | 2026-06-08 |
| Shareholder vote results · Q2 2026 | 2026-06-05 |
| Board / officer change · Q2 2026 | 2026-05-26 |
| Quarterly report · Q1 2026 | 2026-05-08 |
| Proxy statement · Q2 2026 | 2026-04-30 |
| Annual report FY2025 | 2026-02-27 |
| Quarterly report · Q3 2025 | 2025-11-07 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for UFP Technologies Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.